Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from Jenscare Scientific Co. Ltd. Class H ( (HK:9877) ).
Jenscare Scientific Co., Ltd. announced that its LuX-Valve Plus has been approved for inclusion in the Hong Kong-Macao Medicine and Equipment Connect, allowing its commercial clinical application in the Greater Bay Area. This approval is expected to address the urgent treatment needs of patients with tricuspid regurgitation and enhance the company’s market penetration, potentially driving long-term sustainable revenue growth.
More about Jenscare Scientific Co. Ltd. Class H
Jenscare Scientific Co., Ltd. is a company based in the People’s Republic of China, specializing in medical devices. Its primary product, the LuX-Valve Plus, is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. The company focuses on providing advanced medical technology solutions to meet significant unmet clinical needs.
Average Trading Volume: 691,433
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.25B
Find detailed analytics on 9877 stock on TipRanks’ Stock Analysis page.